Rare tumors, major challenges: The RACOON-SAGA project explores how imaging and clinical data can improve the pre-therapeutic characterization of soft tissue sarcomas. In this interview, Dr. Madelaine Hettler from University Medical Center Mannheim explains how radiology and surgery collaborate within the Network University Medicine — and why structured data are key to making therapy decisions more precise and personalized.
Rare Tumors, Big Goals: How RACOON-SAGA Aims to Improve Therapy Decisions
Related Resources
From PCWG3 to PCWG4: Evolving Standards in Prostate Cancer Clinical Trials
The Prostate Cancer Working Group 4 (PCWG4) updates and extends the recommendations of PCWG3 to reflect a patient-centric approach, the emergence of…
Integrated Data Management for Multicentric Imaging in Investigator-Initiated Trials (IITs)
Establishing a Framework for Multicentric Data Coordination
For many investigators, the transition from a single-site study to a multicentric model…
Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer
For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…